AI-generated summary
The authors randomized 46 elderly head and neck cancer patients receiving radiotherapy to low level laser therapy or placebo in a double blinded trial. They report that the laser group had significantly less severe oral mucositis, less severe pain, and less weight loss than the placebo group, with no difference in enteral feeding use.
- Participants
- 46
- Who or what was studied
- Elderly patients with head and neck cancer scheduled for radiotherapy
- Limits stated in the abstract
- The abstract does not describe the sample size calculation, follow-up length, or any limits beyond the modest single-trial design, and the reported p-values are close to the 0.05 threshold.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 36 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Oral mucositis, Low-level laser therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.